Search research articles
Contact Us
Filters
Showing results (1351-1360 of 1,779) with videos related to
Page
of 178
Sort By:
Mabs
|
March 18, 2016
CODV-Ig, a universal bispecific tetravalent and multifunctional immunoglobulin format for medical applications
Anke Steinmetz, François Vallée, Christian Beil, et al.
Mabs
|
March 18, 2016
Transpo-mAb display: Transposition-mediated B cell display and functional screening of full-length IgG antibody libraries
Lorenz Waldmeier, Ina Hellmann, Chantal K Gutknecht, et al.
Mabs
|
March 18, 2016
Conformation-specific anti-Mad2 monoclonal antibodies for the dissection of checkpoint signaling
Garry G Sedgwick, Marie Sofie Yoo Larsen, Tiziana Lischetti, et al.
Mabs
|
December 15, 2015
CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors
Con Panousis, Urmi Dhagat, Kirsten M Edwards, et al.
Mabs
|
May 2, 2022
Physiologically Based Modeling to Predict Monoclonal Antibody Pharmacokinetics in Humans from in vitro Physiochemical Properties
Shihao Hu, Amita Datta-Mannan, David Z D'Argenio
Mabs
|
July 15, 2022
Antibody markup language (AbML) - a notation language for antibody-based drug formats and software for creating and rendering AbML (abYdraw)
James Sweet-Jones, Maham Ahmad, Andrew C R Martin
Mabs
|
September 12, 2018
Establishment of peripheral blood mononuclear cell-derived humanized lung cancer mouse models for studying efficacy of PD-L1/PD-1 targeted immunotherapy
Shouheng Lin, Guohua Huang, Lin Cheng, et al.
Mabs
|
February 25, 2016
A bispecific antibody effectively neutralizes all four serotypes of dengue virus by simultaneous blocking virus attachment and fusion
Xin Shi, Yongqiang Deng, Huajing Wang, et al.
Mabs
|
September 6, 2017
<sup>89</sup>Zr-mAb3481 PET for HER3 tumor status assessment during lapatinib treatment
Martin Pool, Arjan Kol, Steven de Jong, et al.
Mabs
|
April 5, 2017
Arabinosylation of recombinant human immunoglobulin-based protein therapeutics
Patrick Hossler, Christopher Chumsae, Christopher Racicot, et al.
Page
of 178
Search research articles
Search
Showing results (1351-1360 of 1,779) with videos related to
Sort By:
Page
of 178
Mabs
|
March 18, 2016
CODV-Ig, a universal bispecific tetravalent and multifunctional immunoglobulin format for medical applications
Anke Steinmetz, François Vallée, Christian Beil, et al.
Mabs
|
March 18, 2016
Transpo-mAb display: Transposition-mediated B cell display and functional screening of full-length IgG antibody libraries
Lorenz Waldmeier, Ina Hellmann, Chantal K Gutknecht, et al.
Mabs
|
March 18, 2016
Conformation-specific anti-Mad2 monoclonal antibodies for the dissection of checkpoint signaling
Garry G Sedgwick, Marie Sofie Yoo Larsen, Tiziana Lischetti, et al.
Mabs
|
December 15, 2015
CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors
Con Panousis, Urmi Dhagat, Kirsten M Edwards, et al.
Mabs
|
May 2, 2022
Physiologically Based Modeling to Predict Monoclonal Antibody Pharmacokinetics in Humans from in vitro Physiochemical Properties
Shihao Hu, Amita Datta-Mannan, David Z D'Argenio
Mabs
|
July 15, 2022
Antibody markup language (AbML) - a notation language for antibody-based drug formats and software for creating and rendering AbML (abYdraw)
James Sweet-Jones, Maham Ahmad, Andrew C R Martin
Mabs
|
September 12, 2018
Establishment of peripheral blood mononuclear cell-derived humanized lung cancer mouse models for studying efficacy of PD-L1/PD-1 targeted immunotherapy
Shouheng Lin, Guohua Huang, Lin Cheng, et al.
Mabs
|
February 25, 2016
A bispecific antibody effectively neutralizes all four serotypes of dengue virus by simultaneous blocking virus attachment and fusion
Xin Shi, Yongqiang Deng, Huajing Wang, et al.
Mabs
|
September 6, 2017
<sup>89</sup>Zr-mAb3481 PET for HER3 tumor status assessment during lapatinib treatment
Martin Pool, Arjan Kol, Steven de Jong, et al.
Mabs
|
April 5, 2017
Arabinosylation of recombinant human immunoglobulin-based protein therapeutics
Patrick Hossler, Christopher Chumsae, Christopher Racicot, et al.
Page
of 178